- Category
- Micro (2022-23)
- Udyam number
- UDYAM-HR-01-0016906

About Neozen Pharma Private Limited
Data last updated:
Neozen Pharma Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 June 2022.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51909HR2022PTC104413. Its GSTIN is 06AAICN3122F1ZU (Haryana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Banti (Managing Director) and Love Kumar (Managing Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No 45 Sundarpuri Opp. Power House Khuda Khurd, Ambala Cantt, Haryana, India – 133006.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.09 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹2.16 Lakh (net margin 1%) and EBITDA of ₹6.92 Lakh (EBITDA margin 3.3%).
As per MCA filings, the company has open charges of ₹50 Lakh on record. Court records list 7 cases involving the company, including 2 filed by the company and 5 filed against it; 4 cases are pending.
Neozen Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0016906). For more details, the company can be reached via its website neozenpharma.com.
Company details
Recognitions & Rankings of Neozen Pharma
Contact details
Neozen Pharma Private Limited's registered office is in Ambala Cantt, Haryana. Its website is neozenpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No 45 Sundarpuri Opp. Power House Khuda Khurd, Ambala Cantt, Haryana, India – 133006
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Neozen Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neozen Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Neozen Pharma Private Limited, buy the company report.
Financials of Neozen Pharma Private Limited
FY 2025 filings availableNeozen Pharma Private Limited reported revenue of ₹2.09 Cr (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 19% in the latest year. EBITDA rose 112% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹6.92 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹2.16 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.3% | ||
| Net Profit Margin | 1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Neozen Pharma Private Limited, buy the company report.
Board of directors of Neozen Pharma Private Limited
Neozen Pharma has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Banti Also directs: Grenix Labs Private Limited | Managing Director | 16 Jun 2022 | 4 Years 4 Months | Current |
| Ritu Rani Also directs: Aquawin Pharma Private Limited | Additional Director | 18 Jun 2024 | 2 Years 4 Months | Current |
| Love Kumar Also directs: Aquawin Pharma Private Limited | Managing Director | 16 Jun 2022 | 4 Years 4 Months | Current |
| Parveen Kumar Also directs: Aquawin Pharma Private Limited | Managing Director | 16 Jun 2022 | 4 Years 4 Months | Current |
Peer comparison
Neozen Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Suharsh Trade & Holdings Pvt Ltd. | ₹2.09 Cr (FY 2025) | -41.0% | Howrah, West Bengal, India | |||
| Maxis Healthcare (I) Private Limited | ₹2.09 Cr (FY 2024) | 10.0% | Gokal Puri, Delhi, India | |||
| A.S.R.K. Wall Arts Private Limited | ₹2.09 Cr (FY 2019) | 205.0% | Bhilwara, Rajasthan, India | |||
| Kishanlal Mayaram Food Industries Private Limited | ₹2.09 Cr (FY 2024) | -39.0% | Indore, Madhya Pradesh, India | |||
| Proneness Pharmaceuticals Private Limited | ₹2.09 Cr (FY 2025) | 38.0% | Lucknow, Uttar Pradesh, India | |||
| Neozen Pharma Private Limitedthis company | ₹2.09 Cr (FY 2025) | ₹2.16 Lakh | 1% | 19.0% | Ambala Cantt, Haryana, India | |
| V2x Security Solutions Private Limited | ₹2.09 Cr (FY 2024) | 83.0% | Gurgaon, Haryana, India | |||
| QRT Auto Private Limited | ₹2.09 Cr (FY 2024) | 46087.0% | Jaipur, Rajasthan, India | |||
| Elexi Impex Pvt Ltd | ₹2.09 Cr (FY 2024) | -65.0% | Kolkata, West Bengal, India | |||
| Ellip & Soid Electronics and Hotelier Private Limited | ₹2.09 Cr (FY 2025) | 5.0% | Dona Paula Tiswadi, Goa, India | |||
| M and G Creative Designs Private Limited | ₹2.09 Cr (FY 2024) | 805.0% | Delhi, India |
To see the full peer comparison of Neozen Pharma Private Limited, buy the company report.
Auditor
Neozen Pharma Private Limited is audited by S T A V & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S T A V & CO. | FY 2023 | 024510C |
Shareholding
The shareholding of Neozen Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Neozen Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Dec 2024 | 101016374 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Neozen Pharma Private Limited has 7 court cases on record: 2 filed by Neozen Pharma, 5 filed against it. 4 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 5 | 4 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed against the company by Soft Touch Pharmaceutical India Limited | Pending |
| District court, Sonepat, Haryana | Cheque dishonour complaint | Filed against the company by an individual | Pending |
| District court, Yamunanagar, Haryana | Court case (Nia Act) | Filed by the company against individuals | Pending |
| District court, Yamunanagar, Haryana | Court case (Nia Act) | Filed by the company against Shivam Healthcare Pvt Ltd and 1 other | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed against the company by M/S Mevkine Health Thcare | Disposed |
To see the full case history of Neozen Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neozen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Neozen Pharma Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
Neozen Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAICN3122F1ZU | Haryana | Active | 29 Jun 2022 |
To see the full GST registrations and return filing status of Neozen Pharma Private Limited, buy the company report.
Recent activity
Neozen Pharma Private Limited has 5 board changes on record since 2022: 4 appointments and 1 cessation. The latest: Kush Kumar ceased to be Managing Director on 18 Jun 2024.
Frequently asked questions
Neozen Pharma is an active private limited company based in Ambala Cantt, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 June 2022 (4+ years old) and is registered under CIN U51909HR2022PTC104413.
Neozen Pharma has 4 current directors:
- Banti - Managing Director
- Love Kumar - Managing Director
- Parveen Kumar - Managing Director
- Ritu Rani - Additional Director
The latest financial statements of Neozen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Neozen Pharma is 06AAICN3122F1ZU, registered in Haryana.
The CIN (Corporate Identification Number) of Neozen Pharma is U51909HR2022PTC104413. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neozen Pharma has 7 court cases on record: 2 filed by the company and 5 filed against it. 4 are pending.
Neozen Pharma was incorporated on 16 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Neozen Pharma by revenue are Suharsh Trade & Holdings Pvt Ltd, Maxis Healthcare (I) Private Limited, A.S.R.K. Wall Arts Private Limited, Kishanlal Mayaram Food Industries Private Limited, Proneness Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Kush Kumar ceased to be Managing Director on 18 Jun 2024. Ritu Rani was appointed as Additional Director on 18 Jun 2024. Banti was appointed as Managing Director on 16 Jun 2022. Neozen Pharma has 5 board changes on record in total.
Yes, Neozen Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0016906).
Neozen Pharma can be reached through the website neozenpharma.com. Its registered office is in Ambala Cantt, Haryana, India.

